Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Immunology
  •  Brain and Spinal Cord Cancer
  •  Hematology
  •  Targeted Therapy
  •  Prostate Cancer
  •  Blood Cancer
  •  Chemotherapy and Radiotherapy
  •  Lung Cancers

Abstract

Citation: Clin Oncol. 2017;2(1):1294.DOI: 10.25107/2474-1663-v2-id1294

Long-Term Survival of Large (≥3CM) Hepatocellular Carcinoma Treated with Microwave Ablation

Haokang Wei, Simon Chivi and Sohail Contractor

Department of Radiology, Rutgers New Jersey Medical School, USA

*Correspondance to: Sohail Contractor 

 PDF  Full Text Research Article | Open Access

Abstract:

Purpose: To evaluate the long‐term Overall Survival (OS) rate in patients with large (≥3cm) Hepatocellular Carcinoma (HCC) treated with Microwave Ablation (MWA).Materials and
Methods:
19 patients with HCC with tumors size ranging from 3cm-9.5cm were treated with MWA. 15 of the 19 patients had single tumor, 4 patients had multiple tumors. 23 tumors were identified. Lesions were evaluated at 1-, 3‐, and 6-months post ablation using the mRECIST criteria. 12 of the 19 patients had Transhepatic Arterial Chemoembolization (TACE), 8 patients had repeat MWA, and 3 patients had liver transplant subsequently. OS rate was analyzed.Result: The mean follow up period was 22.8 ± 12.8 months, and the range was 2-40 months by the end of study. Out of 23 tumors, 10 tumors had Partial Response (PR), 8 tumors had Complete Response (CR), 3 tumors had Stable Disease (SD), and 2 tumors had Progressive Disease (PD). The 6-month, 1-year and 2-year OS rates were 94.4%, 94.4%, and 85.7% respectively.
Conclusion: MWA is an effective treatment for HCC ≥3cm given its favorable long-term OS rate.

Keywords:

Microwave ablation; Large hepatocellular carcinoma; Long-term survival

Cite the Article:

Wei H, Chivi S, Contractor S. Long- Term Survival of Large (≥3CM) Hepatocellular Carcinoma Treated with Microwave Ablation. Clin Oncol. 2017; 2: 1294.

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Systematic Review and Meta-Analysis of PD-1 and CTLA-4 Bispecific Antibody in the Treatment of Gastric Cancer
 Abstract  PDF  Full Text
Thromboxane-Prostanoid Receptor Signaling as Potential Therapy for Pulmonary Fibrosis
 PDF  Full Text
View More...